Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Molecular Pharmaceutics
|
April 7, 2020
A New [<sup>68</sup>Ga]Ga-HBED-CC-Bisphosphonate as a Bone Imaging Agent
Zhihao Zha, Zehui Wu, Seok Rye Choi, et al.
Nuclear Medicine and Biology
|
May 8, 2010
In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease
Julie L Wang, Shunichi Oya, Ajit K Parhi, et al.
Journal of Medicinal Chemistry
|
October 4, 2016
4-(((4-Iodophenyl)methyl)-4H-1,2,4-triazol-4-ylamino)-benzonitrile: A Potential Imaging Agent for Aromatase
Jin Song, Zehui Wu, Beau Wangtrakuldee, et al.
Nuclear Medicine and Biology
|
July 23, 2019
VMAT2 imaging agent, D6-[<sup>18</sup>F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization
Ruiyue Zhao, Zhihao Zha, Xinyue Yao, et al.
Bioorganic & Medicinal Chemistry
|
February 1, 2020
Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer
Xinyue Yao, Zhihao Zha, Karl Ploessl, et al.
ACS Medicinal Chemistry Letters
|
July 16, 2021
A New Highly Deuterated [<sup>18</sup>F]AV-45, [<sup>18</sup>F]D15FSP, for Imaging β-Amyloid Plaques in the Brain
Hao Xiao, Seok Rye Choi, Ruiyue Zhao, et al.
Journal of Medicinal Chemistry
|
September 5, 2023
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
Zhihao Zha, Karl Ploessl, Seok Rye Choi, et al.
Journal of Medicinal Chemistry
|
September 14, 2022
New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177)
Zhihao Zha, Seok Rye Choi, Linlin Li, et al.
Journal of the American Chemical Society
|
December 31, 2010
Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors
Wenchao Qu, Zhihao Zha, Karl Ploessl, et al.
Journal of Medicinal Chemistry
|
March 7, 2024
Theranostic Agent Targeting Bone Metastasis: A Novel [<sup>68</sup>Ga]Ga/[<sup>177</sup>Lu]Lu-DOTA-HBED-bisphosphonate
Wenbin Jin, Ruiyue Zhao, Ran Wang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Molecular Pharmaceutics
|
April 7, 2020
A New [<sup>68</sup>Ga]Ga-HBED-CC-Bisphosphonate as a Bone Imaging Agent
Zhihao Zha, Zehui Wu, Seok Rye Choi, et al.
Nuclear Medicine and Biology
|
May 8, 2010
In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease
Julie L Wang, Shunichi Oya, Ajit K Parhi, et al.
Journal of Medicinal Chemistry
|
October 4, 2016
4-(((4-Iodophenyl)methyl)-4H-1,2,4-triazol-4-ylamino)-benzonitrile: A Potential Imaging Agent for Aromatase
Jin Song, Zehui Wu, Beau Wangtrakuldee, et al.
Nuclear Medicine and Biology
|
July 23, 2019
VMAT2 imaging agent, D6-[<sup>18</sup>F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization
Ruiyue Zhao, Zhihao Zha, Xinyue Yao, et al.
Bioorganic & Medicinal Chemistry
|
February 1, 2020
Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer
Xinyue Yao, Zhihao Zha, Karl Ploessl, et al.
ACS Medicinal Chemistry Letters
|
July 16, 2021
A New Highly Deuterated [<sup>18</sup>F]AV-45, [<sup>18</sup>F]D15FSP, for Imaging β-Amyloid Plaques in the Brain
Hao Xiao, Seok Rye Choi, Ruiyue Zhao, et al.
Journal of Medicinal Chemistry
|
September 5, 2023
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
Zhihao Zha, Karl Ploessl, Seok Rye Choi, et al.
Journal of Medicinal Chemistry
|
September 14, 2022
New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177)
Zhihao Zha, Seok Rye Choi, Linlin Li, et al.
Journal of the American Chemical Society
|
December 31, 2010
Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors
Wenchao Qu, Zhihao Zha, Karl Ploessl, et al.
Journal of Medicinal Chemistry
|
March 7, 2024
Theranostic Agent Targeting Bone Metastasis: A Novel [<sup>68</sup>Ga]Ga/[<sup>177</sup>Lu]Lu-DOTA-HBED-bisphosphonate
Wenbin Jin, Ruiyue Zhao, Ran Wang, et al.
Page
of 6